Chris Churchill serves as President of both National Cardiovascular Partners and Spectra Laboratories. He is also Senior Vice President, Corporate Strategy and Development, where he is responsible for corporate strategy, supporting business units in the development of their individual strategies, and acquisitions. Prior to his current role, Chris has held several positions at Fresenius, including management of inpatient services, home therapies, marketing, product management and customer experience. Prior to joining Fresenius Medical Care, Chris worked for Iron Mountain where he built and led two of the company’s highest growth business units. Chris began his career with 10 years in investment banking. He holds a bachelor’s degree in economics from Princeton University and Master of Business Administration from Harvard Business School.